Fagron Brasil

What Fagron Brasil does

Fagron Brasil is the Brazilian subsidiary of Fagron, a global pharmaceutical compounding company, headquartered in São Paulo. The company supplies pharmacists, medical prescribers, hospitals, veterinary professionals, and the pharmaceutical industry with personalized medicine formulations, proprietary drug delivery technologies, and the equipment and supplies required for in-pharmacy compounding. Its core technology portfolio centers on proprietary pharmaceutical formulations including Pentravan® (a transdermal delivery vehicle supported by 70+ clinical studies), MaxSolve® (a Coenzyme Q10 formulation claimed to be 500% more bioavailable than standard versions), DiluCap® (capsule excipients), OrPhyllo® (oral administration systems for improved patient adherence), and Ormonelle™ (hormone therapy). Genetic testing services are offered through the Fagron Genomics sub-brand to support personalized prescribing.

The business model combines product sales (proprietary formulations and compounding ingredients), a dedicated solutions platform (Fagron Solutions at fagronsolutions.com.br, offering packaging, equipment, laboratory supplies, analyses, and education/consulting), and professional services (genetic testing through Fagron Genomics). Revenue is generated through direct sales to healthcare professionals and compounding pharmacies, supported by a quote-based pricing approach with no publicly disclosed pricing. The company also operates Fagron Academy as an educational platform and a customer portal for regulatory documentation, deepening engagement with the compounding pharmacy ecosystem.

Fagron Brasil operates as part of Fagron's global footprint of approximately 70 offices and compounding facilities across 30+ countries in EMEA, North America, and Latin America, with a worldwide headcount of 3,100+. The subsidiary functions as the Latin American hub for the parent company, leveraging group-level proprietary IP, clinical evidence, and regulatory documentation while serving the Brazilian market through localized distribution and customer support.

Name

Fagron Brasil

Legal name

Fagron Brasil

Website

https://fagron.com.br

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

Fagron Brasil is the Brazilian subsidiary of Fagron, supplying pharmacists, hospitals, prescribers, and veterinary professionals with proprietary pharmaceutical compounding formulations, drug delivery technologies, equipment, and genetic testing services for personalized medicine.

Ownership category

akta.pro rank

Product category

Pharmaceutical Compounding

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH)

Keywords

• Pharmaceutical compounding
• Personalized medicine
• Transdermal drug delivery
• Compounding pharmacy supplies
• Genetic testing services

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Compounding Products: Sale of proprietary pharmaceutical formulations including transdermal vehicles, bioavailable supplements, and personalized medicine solutions to pharmacists, hospitals, and healthcare providers.
2. Fagron Solutions Platform: Supply of compounding supplies including packaging, equipment, laboratory supplies, laboratory analyses, and education & consulting services to manipulation pharmacies.
3. Fagron Genomics: Genetic testing services enabling personalized medicine for pharmacists, prescribers, hospitals and industry to provide quality, safety and service to patients.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Fagron Brasil manufactures and supplies proprietary pharmaceutical compounding formulations and ingredients for personalized medicine, including transdermal vehicles, bioavailable supplements, oral administration systems, capsule excipients, weight management solutions, hormone therapy, and veterinary compounds. It complements these with the Fagron Solutions platform of compounding pharmacy supplies, equipment, laboratory analyses, education, and consulting, and with Fagron Genomics genetic testing services, selling directly to pharmacists, prescribers, hospitals, veterinarians, and the pharmaceutical industry.

Product overview

Fagron Brasil is a world leader in the pharmaceutical compounding market, operating as a platform company with multiple specialized product sub-brands and service offerings. The core portfolio centers on personalized medicine formulations including transdermal delivery systems (Pentravan®, Ormonelle™), nutritional supplements (Clock®, MaxSolve®), and oral administration systems (OrPhyllo®). Supporting products include DiluCap® for capsule excipients, Fagron VET for animal health, and Fagron Genomics for genetic testing services. The Fagron Solutions platform provides complementary packaging, equipment, lab supplies, and education services. Together, these products enable pharmacists, prescribers, hospitals, and the pharmaceutical industry to deliver quality, safety, and personalized medicine solutions to patients.

Differentiator

Problem solved

Functional benefit

Brands

• Pentravan®: Transdermal vehicle technology with over 70 published or in-progress studies
• Clock®
• MaxSolve®
• OrPhyllo®
• DiluCap®
• Fagron VET
• Fagron Genomics
• Fagron Solutions
• Ormonelle™

Products and services

• Pentravan® A proprietary transdermal vehicle used by pharmacists to deliver active pharmaceutical ingredients through the skin, claimed to be the safest on the market and supported by over 70 published or in-progress clinical studies. It enables compounding pharmacies to formulate personalized transdermal medications.
• MaxSolve® A versatile Coenzyme Q10 supplement with clinically demonstrated 500% higher bioavailability than standard formulations, used for energy support and post-COVID fatigue recovery. Sold through compounding pharmacies to patients.
• DiluCap® A complete line of excipients for hard capsules, supported by studies to guarantee the performance and safety of compounded capsules used by manipulation pharmacies.
• OrPhyllo® A novel oral pharmaceutical ingredient administration system designed to increase patient adherence to treatment through improved oral delivery of compounded medications.
• Ormonelle™ A transdermal innovation product for personalized medicine within the hormone therapy space, part of Fagron's innovative formulations portfolio. Targeted at pharmacists and prescribers for customized hormone treatment.
• Clock® A complete weight management solution offering comprehensive support for personalized weight loss, positioned as a full program rather than a standalone product.
• Fagron VET An exclusive product line providing innovative pharmaceutical compounding solutions for animal health, targeted at veterinary professionals requiring specialized formulations.
• Fagron Genomics Genetic testing services enabling pharmacists, prescribers, hospitals, and the pharmaceutical industry to deliver personalized medicine through genetic insights that guide treatment decisions.
• Fagron Solutions A one-stop-shop platform providing compounding pharmacies with packaging, equipment, laboratory supplies, laboratory analyses, and education & consulting services to support manipulation pharmacy operations.
• Fagron Essentials The complete product portfolio encompassing all Fagron Brasil pharmaceutical compounding solutions and innovations, providing a consolidated view of the full offering for pharmacists and healthcare professionals.

Quantifiable outcome

• 500% higher bioavailability compared to standard Coenzyme Q10 formulations
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Fagron Solutions (fagronsolutions.com.br)coreChannel Partner/ Reseller/ DistributorFagron Solutions operates as a separate platform (fagronsolutions.com.br) providing comprehensive compounding pharmacy supplies including packaging, equipment, laboratory supplies, laboratory analyses, and education & consulting services. It serves as a distribution channel for Fagron's ecosystem of products.

Scale indicators4 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Medisca: Medisca is a North America-based supplier of pharmaceutical compounding ingredients, excipients, and equipment, with a growing international footprint. It directly competes with Fagron in supplying manipulation/compounding pharmacies with APIs and formulation bases.
• Letco Medical (LCT Holdings): Letco Medical is a US specialty distributor of compounding chemicals, equipment, and supplies for compounding pharmacies. It competes directly with Fagron Brasil's Fagron Solutions business in supplying manipulation pharmacies.
• PCCA (Professional Compounding Centers of America): PCCA is a leading US-based compounding pharmacy support organization providing APIs, bases, equipment, and clinical training to compounding pharmacists. It shares Fagron's core model of supporting personalized medicine through pharmacy partnerships.
• Fagron (Parent): Fagron is the publicly-traded parent company of Fagron Brasil, headquartered in Belgium. It is the global market leader in pharmaceutical compounding, offering identical categories of products (APIs, excipients, transdermal vehicles) to compounding pharmacies worldwide.

Regional players

• Eurofarma Laboratórios: Eurofarma is a major Brazilian pharmaceutical manufacturer with a broad branded generics and innovative prescription portfolio. It is a regional incumbent that competes with some of Fagron Brasil's therapeutic categories (e.g., hormone, weight management) through mass-produced alternatives.
• Prati-Donaduzzi: Prati-Donaduzzi is a leading Brazilian generics and contract manufacturer. As a domestic mass-market pharma producer, it competes indirectly with Fagron Brasil in therapeutic categories where mass-produced generics can substitute for compounded alternatives.

Broad incumbents

• Spectrum Chemical: Spectrum Chemical is a large US-based distributor of fine chemicals, APIs, and excipients for pharmaceutical, food, and laboratory use. It serves overlapping customers (compounding pharmacies, hospitals, labs) but operates across broader end-markets beyond compounding.
• Roquette: Roquette is a global starch and polyol producer with a major pharmaceutical excipients business (PEARLITOL, KLEPTOSE). It is a broad incumbent in the pharma inputs space overlapping with Fagron Brasil's excipient offerings to compounding pharmacies.
• DFE Pharma: DFE Pharma is a global supplier of excipients (lactose, starch, superdisintegrants) for oral solid-dose pharmaceuticals. It supplies a category of inputs (excipients) that Fagron Brasil includes in its DiluCap® and broader compounding portfolio.

Others

• IMCD Group: IMCD is a global specialty chemicals and food ingredients distributor serving pharmaceutical, personal care, and industrial markets. It operates in adjacent distribution channels supplying ingredients to pharma and personal care formulators in Latin America.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/fagronbrasil
• LinkedInlinkedin.com/company/fagronbrasil

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fagron Brasil